SCHEMBL4882091

SCHEMBL4882091

Cc1ccc(C)n1-c1ncccc1Br

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 2/20 0.54
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TP53 P04637 2/20 0.35
USP2 O75604 1/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CKS1B P61024 1/20 0.33
SKP2 Q13309 1/20 0.33
NPC1 O15118 1/20 0.33
HSP90AA1 P07900 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21225774 0.79 MYC (0.58) MYCKDM4EALDH1A1NPSR1MEN1
SCHEMBL5660226 0.76 MYC (0.59) MYCKDM4EALDH1A1NPSR1MEN1
SCHEMBL12528795 0.76 MYC (0.36) MYCALDH1A1NOS3NOS1NOS2
SCHEMBL13105276 0.73 LMNA (0.35) MYCKDM4EALDH1A1NPSR1MEN1
SCHEMBL12528798 0.73 MYC (0.34) MYCKDM4EMEN1KMT2ATP53
SCHEMBL12528657 0.73 MYC (0.44) MYCKDM4E
SCHEMBL13105275 0.71 ALDH1A1 (0.36) MYCALDH1A1HTTLMNASMN1; SMN2
SCHEMBL8523412 0.71 KDM4E (0.55) MYCKDM4EALDH1A1NPSR1MEN1
SCHEMBL15714407 0.71 MYC (1.00) MYCKDM4EALDH1A1NPSR1MEN1
SCHEMBL3982909 0.70 KDM4E (0.56) MYCKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102516161-A Pyridine and pyrimidine derivatives as mglur2 antagonists HOFFMANN LA ROCHE 2012-06-27 CN disclosed
CN-101415681-A Pyridine and pyrimidine derivatives as mGluR2 antagonists HOFFMANN LA ROCHE (CH) 2009-04-22 CN disclosed
US-20080267942-A1 BENZAZEPIN-2(1H)-ONE DERIVATIVES PFIZER LIMITED (GB) 2008-10-30 US disclosed
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality PFIZER LIMITED (GB) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality ADRB2, ADRB1, ADRA2C MYC 3446/4885KDM4E 1178/4885ALDH1A1 650/4885
US-20080267942-A1 BENZAZEPIN-2(1H)-ONE DERIVATIVES ADRB2, ADRB1, ADRA2C MYC 3051/4885KDM4E 3904/4885ALDH1A1 645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.